申请人:Madsen Siim Lars
公开号:US20050080112A1
公开(公告)日:2005-04-14
The present invention relates to the use certain compounds for the treatment, prevention or alleviation of a disorder or disease of a subject, which disorder or disease is responsive to modulation of the mast cell or basophil activity of such a subject.
本发明涉及使用某些化合物来治疗、预防或减轻受试者的失调或疾病,这种失调或疾病对调节受试者肥大细胞或嗜碱性粒细胞的活性有反应。